EUVIMEDEUVIMED entdecken
Crossref

Empagliflozin significantly prevents QTc prolongation due to amitriptyline intoxication

Veysel Özgür Barış, Esra Gedikli, Adnan Berk Dinçsoy, Ayşen Erdem

Cardiovascular Journal of Africa · 2024

DOI: 10.5830/cvja-2023-017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Journal of Africa, 2024. Verfasst von Veysel Özgür Barış und 3 weiteren Autor:innen. Beteiligte Einrichtung: Physiology Department, Hacettepe University, Gaziantep, Turkey. Email: veyselozgurbaris@gmail.com. Hauptthemen laut MEDLINE: Benzhydryl Compounds, Amitriptyline, Glucosides, Sodium-Glucose Transporter 2 Inhibitors.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIM: Empagliflozin (EMPA) is a sodium-glucose transporter-2 inhibitor used in the treatment of type 2 diabetes and has positive effects on cardiovascular outcomes. Amitriptyline (AMT) can be used in many clinical indications but leads to cardiotoxicity by causing QT prolongation. Our aim in this study was to determine how the effects of the concomitant use of empagliflozin and amitriptyline, which have been shown to have effects on sodium and calcium metabolism in cardiomyocytes, would cause an effect on QT and QTc intervals in clinical practice. METHODS: Twenty-four male Wistar albino rats were randomised into four groups. The control group received only physiological serum (1 ml) via orogastric gavage (OG). The EMPA group received empagliflozin (10 mg/kg) via OG. The AMT group received amitriptyline (100 mg/kg) via OG. The AMT + EMPA group (n = 6) received amitriptyline (100 mg/kg) and empagliflozin (10 mg/kg). Under anaesthesia, QT and QTc intervals were measured at baseline, and in the first and second hours. RESULTS: In the AMT group, QT intervals and QTc values were found to be statistically longer than in the control group (p ≤ 0.001). Empagliflozin significantly ameliorated amitriptyline-induced QT and QTc prolongation. In the AMT + EMPA group, QT and QTc intervals were significantly lower compared to that in the AMT group (p < 0.01). CONCLUSION: In this study, we determined that empagliflozin significantly ameliorated amitriptyline-induced QT and QTc prolongation. This effect was probably due to the opposite effects of these two agents in the intracellular calcium balance. With more clinical trials, the routine use of empagliflozin may be suggested to prevent QT and QTc prolongation in diabetic patients receiving amitriptyline.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Benzhydryl CompoundsAmitriptylineGlucosidesSodium-Glucose Transporter 2 InhibitorsHeart RateLong QT SyndromeHeart Conduction SystemAnimalsMaleRats, WistarCardiotoxicityTime FactorsAction PotentialsElectrocardiography

Stichwörter der Autor:innen

QTc prolongationamitriptylineempagliflozin

Substanzen

Benzhydryl CompoundsempagliflozinAmitriptylineGlucosidesSodium-Glucose Transporter 2 Inhibitors

Autor:innen und Institutionen

  • Physiology Department, Hacettepe University, Gaziantep, Turkey. Email: veyselozgurbaris@gmail.com.
  • Physiology Department, Hacettepe University, Gaziantep, Turkey.

Zitieren

APA

Barış, V. Ö., Gedikli, E., Dinçsoy, A. B., & Erdem, A. (2024). Empagliflozin significantly prevents QTc prolongation due to amitriptyline intoxication. Cardiovascular Journal of Africa. https://doi.org/10.5830/cvja-2023-017

Vancouver

Barış VÖ, Gedikli E, Dinçsoy AB, Erdem A. Empagliflozin significantly prevents QTc prolongation due to amitriptyline intoxication. Cardiovascular Journal of Africa. 2024. doi:10.5830/cvja-2023-017

BibTeX
@article{Bar2024,
  author = {Barış, Veysel Özgür and Gedikli, Esra and Dinçsoy, Adnan Berk and Erdem, Ayşen},
  title = {Empagliflozin significantly prevents QTc prolongation due to amitriptyline intoxication},
  journal = {Cardiovascular Journal of Africa},
  year = {2024},
  doi = {10.5830/cvja-2023-017}
}
Kostenlos starten →